NASDAQ: ONC
Beone Medicines Ltd Stock Ownership - Who owns Beone Medicines?

Insider buying vs selling

Have Beone Medicines Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Corazon Corsee D. SandersDirector2025-11-262,627$159.03
$417.77kBuy
Corazon Corsee D. SandersDirector2025-11-26804$342.47
$275.35kSell
Corazon Corsee D. SandersDirector2025-11-261,823$340.20
$620.18kSell
Xiaobin WuPresident and COO2025-11-17826$381.19
$314.86kSell
Xiaobin WuPresident and COO2025-11-173,155$380.23
$1.20MSell
Xiaobin WuPresident and COO2025-11-1710$382.32
$3.82kSell
Xiaobin WuPresident and COO2025-11-134,240$380.33
$1.61MSell
Xiaobin WuPresident and COO2025-11-131,769$381.05
$674.08kSell
Xiaobin WuPresident and COO2025-11-12120$355.00
$42.60kSell
Xiaobin WuPresident and COO2025-11-12154$362.07
$55.76kSell

1 of 27

ONC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONC insiders and whales buy or sell their stock.

ONC Shareholders

What type of owners hold Beone Medicines Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Capital Advisors Ltd10.22%147,035,258$48.55BInsider
Hhlr Advisors Ltd8.69%125,045,741$41.29BInsider
Hillhouse Capital Management Ltd7.71%110,866,146$36.61BInsider
Cb Biotech Investment Ltd1.36%19,601,138$6.47BInsider
Amgen Inc1.32%18,943,802$6.25BInsider
Baker Bros Advisors LP0.61%8,799,053$2.91BInstitution
Baker Bros Advisors LP0.56%8,078,829$2.67BInsider
Merck Co Inc0.55%7,942,314$2.62BInsider
John Oyler0.45%6,543,229$2.16BInsider
Xiaodong Wang0.38%5,491,395$1.81BInsider

1 of 3

ONC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONC2.29%32.11%Net BuyingNet Selling
INSM84.89%15.11%Net SellingNet Selling
BNTX20.98%0.00%
RPRX56.74%17.41%Net SellingNet Selling
UTHR86.69%13.31%Net SellingNet Selling

Beone Medicines Stock Ownership FAQ

Who owns Beone Medicines?

Beone Medicines (NASDAQ: ONC) is owned by 2.29% institutional shareholders, 32.11% Beone Medicines insiders, and 65.60% retail investors. Hillhouse Capital Advisors Ltd is the largest individual Beone Medicines shareholder, owning 147.04M shares representing 10.22% of the company. Hillhouse Capital Advisors Ltd's Beone Medicines shares are currently valued at $48.55B.

If you're new to stock investing, here's how to buy Beone Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.